Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids.

[1]  A. Woodcock,et al.  Dose effect of once-daily fluticasone furoate in persistent asthma: a randomized trial. , 2012, Respiratory medicine.

[2]  A. Woodcock,et al.  Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial , 2011, Thorax.

[3]  H. Kelly.  Inhaled corticosteroid dosing: double for nothing? , 2011, The Journal of allergy and clinical immunology.

[4]  D. Postma,et al.  Prolonged protection of the new inhaled corticosteroid fluticasone furoate against AMP hyperresponsiveness in patients with asthma , 2010, Allergy.

[5]  J. Lötvall,et al.  Multi-symptom asthma is closely related to nasal blockage, rhinorrhea and symptoms of chronic rhinosinusitis-evidence from the West Sweden Asthma Study , 2010, Respiratory research.

[6]  E. R. Sutherland,et al.  Tiotropium bromide step-up therapy for adults with uncontrolled asthma. , 2010, The New England journal of medicine.

[7]  W. Lincourt,et al.  Predictors of Uncontrolled Asthma in Adult and Pediatric Patients: Analysis of the Asthma Control Characteristics and Prevalence Survey Studies (ACCESS) , 2010, The Journal of asthma : official journal of the Association for the Care of Asthma.

[8]  D. Curran‐Everett,et al.  Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. , 2010, American journal of respiratory and critical care medicine.

[9]  D. Price,et al.  Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study , 2010, BMC pulmonary medicine.

[10]  W. Lincourt,et al.  Assessment of asthma control in primary care , 2009, Current medical research and opinion.

[11]  M. Cazzola,et al.  Novel long‐acting bronchodilators for COPD and asthma , 2008, British journal of pharmacology.

[12]  H. Ortega,et al.  Meta-analysis: Effects of Adding Salmeterol to Inhaled Corticosteroids on Serious Asthma-Related Events , 2008, Annals of Internal Medicine.

[13]  I. McLay,et al.  X-ray crystal structure of the novel enhanced-affinity glucocorticoid agonist fluticasone furoate in the glucocorticoid receptor-ligand binding domain. , 2008, Journal of medicinal chemistry.

[14]  Martyn R Partridge,et al.  British Guideline on the Management of Asthma , 2008, Thorax.

[15]  J. Lötvall,et al.  Comparison of the efficacy of salmeterol/fluticasone propionate combination in Japanese and Caucasian asthmatics. , 2007, Respiratory medicine.

[16]  C. Iribarren,et al.  Effect of race on asthma management and outcomes in a large, integrated managed care organization. , 2007, Archives of Internal Medicine.

[17]  S. Farrow,et al.  Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[18]  Donald H. Arnold,et al.  Clinical measures associated with FEV1 in persons with asthma requiring hospital admission. , 2007, The American journal of emergency medicine.

[19]  D. Curran‐Everett,et al.  Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. , 2007, The Journal of allergy and clinical immunology.

[20]  R. Pauwels,et al.  Effectiveness of early budesonide intervention in Caucasian versus Asian patients with asthma: 3‐year results of the START study , 2006, Respirology.

[21]  P. Gibson,et al.  Asthma exacerbations · 4: Prevention , 2006, Thorax.

[22]  P. Jones,et al.  The dose-response characteristics of inhaled corticosteroids when used to treat asthma: an overview of Cochrane systematic reviews. , 2006, Respiratory medicine.

[23]  Linda Abetz,et al.  Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. , 2006, Respiratory medicine.

[24]  J. Guest,et al.  Switching asthma patients to a once-daily inhaled steroid improves compliance and reduces healthcare costs. , 2005, Primary care respiratory journal : journal of the General Practice Airways Group.

[25]  E. R. Sutherland,et al.  Nocturnal asthma: underlying mechanisms and treatment , 2005, Current allergy and asthma reports.

[26]  Kevin B Weiss,et al.  Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. , 2004, The Journal of allergy and clinical immunology.

[27]  J. C. Carranza Rosenzweig,et al.  Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. , 2004, The Journal of allergy and clinical immunology.

[28]  William W Busse,et al.  Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial , 2003, The Lancet.

[29]  N. Santanello,et al.  Adherence to Prescribed Treatment for Asthma: Evidence from Pharmacy Benefits Data , 2003, The Journal of asthma : official journal of the Association for the Care of Asthma.

[30]  D. Postma,et al.  Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening. , 2001, The European respiratory journal.

[31]  J. Matz,et al.  Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations. , 2001, The Journal of allergy and clinical immunology.

[32]  S. Suissa,et al.  Low-dose inhaled corticosteroids and the prevention of death from asthma. , 2000, The New England journal of medicine.

[33]  R Horne,et al.  Compliance in asthma. , 1999, Respiratory medicine.

[34]  D. Postma,et al.  Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. , 1997, The New England journal of medicine.

[35]  Third Expert Panel on theDiagnosis,et al.  Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma , 1997 .

[36]  P. O'Byrne,et al.  A comparison of the efficacy and safety of inhaled corticosteroids in asthma , 1997, Allergy.

[37]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[38]  F. Hampel,et al.  Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging study. , 1996, Clinical therapeutics.

[39]  T. Haahtela,et al.  Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. , 1994, The New England journal of medicine.

[40]  P. Ind,et al.  Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid , 1994, The Lancet.

[41]  C. G. Langdon,et al.  Pulmicort Turbohaler once daily as initial prophylactic therapy for asthma. , 1994, Respiratory medicine.

[42]  R. Martin,et al.  Nocturnal asthma: circadian rhythms and therapeutic interventions. , 1993, The American review of respiratory disease.

[43]  A. Miller,et al.  Lung function testing: selection of reference values and interpretative strategies. , 1992, The American review of respiratory disease.

[44]  I. Pavord,et al.  An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. , 2009, American journal of respiratory and critical care medicine.

[45]  A. Tattersfield,et al.  Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help? , 2008 .

[46]  M. Weatherall,et al.  Clinical dose-response relationship of fluticasone propionate in adults with asthma. , 2004, Thorax.

[47]  D. Webb,et al.  Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[48]  J L Hankinson,et al.  Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.

[49]  D. Kellerman,et al.  A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma. , 1996, The Journal of asthma : official journal of the Association for the Care of Asthma.